Axsome Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Axsome Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Axsome Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Axsome Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $25M | 209k | 121.45 |
| 2025-06-30 | $24M | 225k | 104.39 |
| 2025-03-31 | $21M | 176k | 116.63 |
| 2024-12-31 | $6.2M | 74k | 84.61 |
| 2023-12-31 | $1.1M | 14k | 79.59 |
| 2022-03-31 | $381k | 9.2k | 41.44 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management